Two high-rate pentose-phosphate pathways in cancer cells

Abstract The relevant role of pentose phosphate pathway (PPP) in cancer metabolic reprogramming has been usually outlined by studying glucose-6-phosphate dehydrogenase (G6PD). However, recent evidence suggests an unexpected role for a less characterized PPP, triggered by hexose-6-phosphate dehydroge...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vanessa Cossu, Marcella Bonanomi, Matteo Bauckneht, Silvia Ravera, Nicole Righi, Alberto Miceli, Silvia Morbelli, Anna Maria Orengo, Patrizia Piccioli, Silvia Bruno, Daniela Gaglio, Gianmario Sambuceti, Cecilia Marini
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/dcc05ac72c4a498785c00b45a4a47e1d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:dcc05ac72c4a498785c00b45a4a47e1d
record_format dspace
spelling oai:doaj.org-article:dcc05ac72c4a498785c00b45a4a47e1d2021-12-02T12:40:40ZTwo high-rate pentose-phosphate pathways in cancer cells10.1038/s41598-020-79185-22045-2322https://doaj.org/article/dcc05ac72c4a498785c00b45a4a47e1d2020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-79185-2https://doaj.org/toc/2045-2322Abstract The relevant role of pentose phosphate pathway (PPP) in cancer metabolic reprogramming has been usually outlined by studying glucose-6-phosphate dehydrogenase (G6PD). However, recent evidence suggests an unexpected role for a less characterized PPP, triggered by hexose-6-phosphate dehydrogenase (H6PD) within the endoplasmic reticulum (ER). Studying H6PD biological role in breast and lung cancer, here we show that gene silencing of this reticular enzyme decreases cell content of PPP intermediates and d-ribose, to a similar extent as G6PD silencing. Decrease in overall NADPH content and increase in cell oxidative status are also comparable. Finally, either gene silencing impairs at a similar degree cell proliferating activity. This unexpected response occurs despite the absence of any cross-interference between the expression of both G6PD and H6PD. Thus, overall cancer PPP reflects the contribution of two different pathways located in the cytosol and ER, respectively. Disregarding the reticular pathway might hamper our comprehension of PPP role in cancer cell biology.Vanessa CossuMarcella BonanomiMatteo BaucknehtSilvia RaveraNicole RighiAlberto MiceliSilvia MorbelliAnna Maria OrengoPatrizia PiccioliSilvia BrunoDaniela GaglioGianmario SambucetiCecilia MariniNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Vanessa Cossu
Marcella Bonanomi
Matteo Bauckneht
Silvia Ravera
Nicole Righi
Alberto Miceli
Silvia Morbelli
Anna Maria Orengo
Patrizia Piccioli
Silvia Bruno
Daniela Gaglio
Gianmario Sambuceti
Cecilia Marini
Two high-rate pentose-phosphate pathways in cancer cells
description Abstract The relevant role of pentose phosphate pathway (PPP) in cancer metabolic reprogramming has been usually outlined by studying glucose-6-phosphate dehydrogenase (G6PD). However, recent evidence suggests an unexpected role for a less characterized PPP, triggered by hexose-6-phosphate dehydrogenase (H6PD) within the endoplasmic reticulum (ER). Studying H6PD biological role in breast and lung cancer, here we show that gene silencing of this reticular enzyme decreases cell content of PPP intermediates and d-ribose, to a similar extent as G6PD silencing. Decrease in overall NADPH content and increase in cell oxidative status are also comparable. Finally, either gene silencing impairs at a similar degree cell proliferating activity. This unexpected response occurs despite the absence of any cross-interference between the expression of both G6PD and H6PD. Thus, overall cancer PPP reflects the contribution of two different pathways located in the cytosol and ER, respectively. Disregarding the reticular pathway might hamper our comprehension of PPP role in cancer cell biology.
format article
author Vanessa Cossu
Marcella Bonanomi
Matteo Bauckneht
Silvia Ravera
Nicole Righi
Alberto Miceli
Silvia Morbelli
Anna Maria Orengo
Patrizia Piccioli
Silvia Bruno
Daniela Gaglio
Gianmario Sambuceti
Cecilia Marini
author_facet Vanessa Cossu
Marcella Bonanomi
Matteo Bauckneht
Silvia Ravera
Nicole Righi
Alberto Miceli
Silvia Morbelli
Anna Maria Orengo
Patrizia Piccioli
Silvia Bruno
Daniela Gaglio
Gianmario Sambuceti
Cecilia Marini
author_sort Vanessa Cossu
title Two high-rate pentose-phosphate pathways in cancer cells
title_short Two high-rate pentose-phosphate pathways in cancer cells
title_full Two high-rate pentose-phosphate pathways in cancer cells
title_fullStr Two high-rate pentose-phosphate pathways in cancer cells
title_full_unstemmed Two high-rate pentose-phosphate pathways in cancer cells
title_sort two high-rate pentose-phosphate pathways in cancer cells
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/dcc05ac72c4a498785c00b45a4a47e1d
work_keys_str_mv AT vanessacossu twohighratepentosephosphatepathwaysincancercells
AT marcellabonanomi twohighratepentosephosphatepathwaysincancercells
AT matteobauckneht twohighratepentosephosphatepathwaysincancercells
AT silviaravera twohighratepentosephosphatepathwaysincancercells
AT nicolerighi twohighratepentosephosphatepathwaysincancercells
AT albertomiceli twohighratepentosephosphatepathwaysincancercells
AT silviamorbelli twohighratepentosephosphatepathwaysincancercells
AT annamariaorengo twohighratepentosephosphatepathwaysincancercells
AT patriziapiccioli twohighratepentosephosphatepathwaysincancercells
AT silviabruno twohighratepentosephosphatepathwaysincancercells
AT danielagaglio twohighratepentosephosphatepathwaysincancercells
AT gianmariosambuceti twohighratepentosephosphatepathwaysincancercells
AT ceciliamarini twohighratepentosephosphatepathwaysincancercells
_version_ 1718393771048042496